Mankind Pharma cuts stock-outs 75% with AI-driven supply chain optimization

Mankind Pharma faced persistent stock-outs across its pharmaceutical supply chain, a problem compounded by strict regulatory requirements, temperature-sensitive products, expiration date management, and unpredictable demand spikes driven by seasonal patterns and disease outbreaks. Traditional forecasting methods were unable to handle the intersection of these variables effectively.

The company implemented an AI-driven supply chain model incorporating AI-powered demand forecasting that ingests external signals (weather, disease trends, seasonal patterns) alongside internal inventory and production data. The system continuously optimizes reorder points in real time across multiple distribution locations and provides early warning of potential shortages weeks in advance.

Mankind Pharma achieved a 75 percent reduction in stock-outs following the AI implementation, improving both product availability for patients and operational cost management. The deployment demonstrated that AI can address complex, multi-variable supply chain challenges in a regulated pharmaceutical environment without compromising compliance requirements.

• Clean, unified data infrastructure connecting demand signals, inventory positions, and supply constraints is a prerequisite before AI can deliver reliable forecasts.
• Starting with highest-volume or most critical SKUs accelerates proof-of-concept and builds organizational confidence before broader rollout.
• Change management is as important as the technology: AI recommendations can seem counterintuitive to experienced planners, requiring clear processes for human oversight of exceptional situations.